0

Amgen Inc (AMGN) – Financial and Strategic SWOT Analysis Review

Publisher Name :
Date: 15-Mar-2017
No. of pages: 70

Amgen Inc (AMGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products by using advanced human genetics to unravel the difficulties of disease and understand the fundamentals of human biology. Amgen sells its products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers by television advertising, direct-to-consumer print and multi-channel marketing. Amgen is headquartered in Thousand Oaks, California, the US.

Amgen Inc Key Recent Developments

Mar 06, 2017: Coherus Addresses Trade Secret Action Filed by Amgen
Feb 03, 2017: Amgen Announces Appointment of Charles M. Holley Jr. to Board of Directors
Feb 02, 2017: Amgen Reports Fourth Quarter And Full Year 2016 Financial Results
Jan 09, 2017: DaVita Enters Into New Sourcing and Supply Agreement with Amgen and Initiates 2017 Kidney Care Guidance
Nov 02, 2016: Amgen Appoints Lori Johnston As Senior Vice President, Human Resources

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Amgen Inc - Key Facts 6
Amgen Inc - Key Employees 7
Amgen Inc - Key Employee Biographies 9
Amgen Inc - Major Products and Services 10
Amgen Inc - Pharmaceutical Pipeline Products Data 11
Amgen Inc, Pipeline Products by Therapy Area 11
Amgen Inc, Pipeline Products by Development Phase 12
Amgen Inc - History 13
Amgen Inc - Company Statement 24
Amgen Inc - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 32
Section 2 - Company Analysis 33
Amgen Inc - Business Description 33
Amgen Inc - Corporate Strategy 35
Amgen Inc - SWOT Analysis 36
SWOT Analysis - Overview 36
Amgen Inc - Strengths 36
Amgen Inc - Weaknesses 37
Amgen Inc - Opportunities 38
Amgen Inc - Threats 40
Amgen Inc - Key Competitors 41
Section 3 - Company Financial Ratios 42
Financial Ratios - Capital Market Ratios 42
Financial Ratios - Annual Ratios 43
Performance Chart 45
Financial Performance 45
Financial Ratios - Interim Ratios 46
Financial Ratios - Ratio Charts 47
Section 4 - Company's Lifesciences Financial Deals and Alliances 48
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 48
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 49
Amgen Inc, Recent Deals Summary 50
Section 5 - Company's Recent Developments 51
Mar 06, 2017: Coherus Addresses Trade Secret Action Filed by Amgen 51
Feb 03, 2017: Amgen Announces Appointment of Charles M. Holley Jr. to Board of Directors 52
Feb 02, 2017: Amgen Reports Fourth Quarter And Full Year 2016 Financial Results 53
Jan 09, 2017: DaVita Enters Into New Sourcing and Supply Agreement with Amgen and Initiates 2017 Kidney Care Guidance 56
Nov 02, 2016: Amgen Appoints Lori Johnston As Senior Vice President, Human Resources 57
Oct 27, 2016: Amgen Reports Third Quarter 2016 Financial Results 58
Oct 17, 2016: West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices 61
Oct 14, 2016: Amgen Announces Appointment Of Ellen J. Kullman To Board Of Directors 63
Sep 26, 2016: Amgen Opens Nomination Process For LabCentral Residency 64
Sep 06, 2016: Syngene International Commissions Dedicated R&D Center for Amgen 65
Section 6 - Appendix 66
Methodology 66
Ratio Definitions 66
About GlobalData 70
Contact Us 70
Disclaimer 70

List of Tables
Amgen Inc, Key Facts 6
Amgen Inc, Key Employees 7
Amgen Inc, Key Employee Biographies 9
Amgen Inc, Major Products and Services 10
Amgen Inc, Number of Pipeline Products by Therapy Area 11
Amgen Inc, Number of Pipeline Products by Development Stage 12
Amgen Inc, History 13
Amgen Inc, Other Locations 26
Amgen Inc, Subsidiaries 28
Amgen Inc, Joint Venture 32
Amgen Inc, Key Competitors 41
Amgen Inc, Ratios based on current share price 42
Amgen Inc, Annual Ratios 43
Amgen Inc (Cont...1), Annual Ratios 44
Amgen Inc, Interim Ratios 46
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 48
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 49
Amgen Inc, Recent Deals Summary 50
Currency Codes 66
Capital Market Ratios 66
Equity Ratios 67
Profitability Ratios 67
Cost Ratios 68
Liquidity Ratios 68
Leverage Ratios 68
Efficiency Ratios 69

List of Figures
Amgen Inc, Pipeline Products by Therapy Area 11
Amgen Inc, Pipeline Products by Development Phase 12
Amgen Inc, Performance Chart (2012 - 2016) 45
Amgen Inc, Ratio Charts 47
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 48
Amgen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 49

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2017 RnR Company Profiles. All rights reserved.